Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Paratyphi A flagellin, primarily the FliC protein, is the major structural subunit that polymerizes to form the helical filaments of bacterial flagella, enabling motility on surfaces and within host cell cytosol.[1][2][5][6] In this human-restricted typhoidal serovar, which causes paratyphoid fever, flagellin supports key virulence processes including epithelial cell invasion, macrophage uptake, and evasion of xenophagy through flagella-mediated cytosolic movement, independent of swimming motility in some contexts.[1][2][3][4] Unlike polyphasic serovars like S. Typhimurium, S. Paratyphi A is monophasic due to genomic inactivation of genes like hin, expressing only phase 1 FliC flagellin at lower levels, which correlates with reduced motility but retained invasion capability.[1][2] Absence of FliC uniquely upregulates the flagellar regulon and Salmonella pathogenicity island 1 (SPI-1) in a FliZ-dependent manner, leading to oversecretion of SPI-1 effectors via type III secretion system 1, enhancing invasion without affecting adhesion.[1][2] Flagellin also contributes to host immune recognition as a Toll-like receptor 5 agonist, though no approved drugs directly target it therapeutically.[9] These features distinguish S. Paratyphi A pathogenesis from nontyphoidal Salmonella, underscoring flagellin's regulatory role in systemic infection.[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Paratyphi A flagellin (FliC) (FliC).